Your browser doesn't support javascript.
loading
Sodium bicarbonate nanoparticles modulate the tumor pH and enhance the cellular uptake of doxorubicin.
Abumanhal-Masarweh, Hanan; Koren, Lilach; Zinger, Assaf; Yaari, Zvi; Krinsky, Nitzan; Kaneti, Galoz; Dahan, Nitsan; Lupu-Haber, Yael; Suss-Toby, Edith; Weiss-Messer, Esther; Schlesinger-Laufer, Michal; Shainsky-Roitman, Janna; Schroeder, Avi.
Afiliación
  • Abumanhal-Masarweh H; Laboratory for Targeted Drug Delivery and Personalized Medicine Technologies, Department of Chemical Engineering, Technion - Israel Institute of Technology, Haifa 32000, Israel; Russell Berrie Nanotechnology Institute, The Norman Seiden Multidisciplinary Graduate Program, Technion - Israel Institute
  • Koren L; Laboratory for Targeted Drug Delivery and Personalized Medicine Technologies, Department of Chemical Engineering, Technion - Israel Institute of Technology, Haifa 32000, Israel.
  • Zinger A; Laboratory for Targeted Drug Delivery and Personalized Medicine Technologies, Department of Chemical Engineering, Technion - Israel Institute of Technology, Haifa 32000, Israel.
  • Yaari Z; Laboratory for Targeted Drug Delivery and Personalized Medicine Technologies, Department of Chemical Engineering, Technion - Israel Institute of Technology, Haifa 32000, Israel.
  • Krinsky N; Laboratory for Targeted Drug Delivery and Personalized Medicine Technologies, Department of Chemical Engineering, Technion - Israel Institute of Technology, Haifa 32000, Israel; The Interdisciplinary Program for Biotechnology, Technion - Israel Institute of Technology, Haifa 32000, Israel.
  • Kaneti G; Laboratory for Targeted Drug Delivery and Personalized Medicine Technologies, Department of Chemical Engineering, Technion - Israel Institute of Technology, Haifa 32000, Israel.
  • Dahan N; Life Sciences and Engineering Infrastructure Center, Lorry I. Lokey Interdisciplinary Center, Technion - Israel Institute of Technology, Haifa 32000, Israel.
  • Lupu-Haber Y; Life Sciences and Engineering Infrastructure Center, Lorry I. Lokey Interdisciplinary Center, Technion - Israel Institute of Technology, Haifa 32000, Israel.
  • Suss-Toby E; Bioimging Center, Biomedical Core Facility, Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa 32000, Israel.
  • Weiss-Messer E; Bioimging Center, Biomedical Core Facility, Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa 32000, Israel.
  • Schlesinger-Laufer M; The Pre-Clinical Research Authority Unit, Technion - Israel Institute of Technology, Haifa 32000, Israel.
  • Shainsky-Roitman J; Laboratory for Targeted Drug Delivery and Personalized Medicine Technologies, Department of Chemical Engineering, Technion - Israel Institute of Technology, Haifa 32000, Israel.
  • Schroeder A; Laboratory for Targeted Drug Delivery and Personalized Medicine Technologies, Department of Chemical Engineering, Technion - Israel Institute of Technology, Haifa 32000, Israel. Electronic address: avids@technion.ac.il.
J Control Release ; 296: 1-13, 2019 02 28.
Article en En | MEDLINE | ID: mdl-30615983
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Doxorrubicina / Bicarbonato de Sodio / Nanopartículas / Neoplasias / Antineoplásicos Límite: Animals / Female / Humans Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Doxorrubicina / Bicarbonato de Sodio / Nanopartículas / Neoplasias / Antineoplásicos Límite: Animals / Female / Humans Idioma: En Año: 2019 Tipo del documento: Article